Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 24, 2012 - Issue 1
205
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen

, , , , , , & show all
Pages 54-58 | Received 20 Aug 2010, Accepted 07 Jun 2011, Published online: 29 Jul 2011

References

  • Airoldi , M. , Zaccarelli , M. , Bisi , L. , Bini , T. , Antinori , A. , Mussini , C. and Maggiolo , F. 2010 . One-pill once-a-day HAART: A simplification strategy that improves adherence and quality of life of HIV-infected subjects . Patient Preference and Adherence , 4 : 115 – 125 .
  • Belzer , M.E. , Fuchs , D.N. , Luftman , G.S. and Tucker , D.J. 1999 . Antiretroviral adherence issues among HIV-positive adolescents and young adults . Journal of Adolescent Health Care , 25 : 316 – 319 .
  • Bonora , S. , Nicastri , E. , Calcagno , A. , Gonzalez de Requena , D. , D'Ettorre , G. , Sarmati , L. and Andreoni , M. 2009 . Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: A cross-sectional evaluation . Journal of Medical Virology , 81 : 400 – 405 .
  • Boyle , B. , Jayaweera , D. , Witt , M.D. , Grimm , K. , Maa , J.F. and Seekins , D.W. 2008 . Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves adherence while maintaining viral suppression . HIV Clinical Trials , 9 : 164 – 176 .
  • Dejesus , E. , Young , B. , Morales-Ramirez , J.O. , Sloan , L. , Ward , D.J. , Flaherty , J.F. , AI266073 Study Group . 2009 . Simplification of antiretroviral therapy to a single tablet regimen consisting of efavirenz, emtricitabine, and tenofovir DF versus unmodified antiretroviral therapy in virologically suppressed, HIV-1infected patients . Journal of Acquired Immune Deficiency Syndromes 51 , 163 – 174 .
  • Flandre , P. , Peytavin , G. , Meifreddy , V. , Saidi , Y. , Descamps , D. , Delagnes , M. , Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team . 2002 . Adherence to antiretroviral therapy and outcomes in HIV infected patients enrolled in an induction/maintenance randomized trial . Antiviral Therapy 7 , 113 – 121 .
  • Flynn , P.M. , Rudy , B.J. , Douglas , S.D. , Lathey , J. , Spector , S.A. , Martinez , J. , Pediatric AIDS Clinical Trial Group 381 Study Team . 2004 . Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy . The Journal of infectious diseases 190 , 271 – 279 .
  • Giordano , T.P. , Guzman , D. , Clark , R. , Charlebois , E.D. and Bangsberg , D.R. 2004 . Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale . HIV Clinical Trials , 5 : 74 – 79 .
  • Harding , R. , Molloy , T. , Easterbrook , P. , Frame , K. and Higginson , I.J. 2006 . Is antiretroviral therapy associated with symptom prevalence and burden? . International Journal of STD and AIDS , 17 : 400 – 405 .
  • Hodder , S.L. , Mounzer , K. , Dejesus , E. , Ebrahimi , R. , Grimm , K. , Esker , S. , AI266073 Study Group 2010 . Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF . AIDS Patient Care STDS 24 , 87 – 96 .
  • Holzemer , W.L. , Corless , I.B. , Nokes , K.M. , Turner , J.G. , Brown , M.A. , Powell-Cope , G.M. and Portillo , C.J. 1999 . Predictors of self-reported adherence in persons living with HIV disease . AIDS Patient Care STD , 13 : 185 – 197 .
  • Justice , A.C. , Holmes , W. , Gifford , A.L. , Rabeneck , L. , Zackin , R. , Sinclair , G. , Adult AIDS Clinical Trials Unit Outcomes Committee 2001 . Development and validation of a self-completed HIV symptom index . Journal of Clinical Epidemiology 54 Suppl. 1 , S77 – S90 .
  • Levi , R. and Drotar , D. 1998 . “ Critical issues and needs in health-related quality of life assessment of children and adolescents with chronic health conditions ” . In Measuring health-related quality of life in children and adolescents , Edited by: Drotar , D. New Jersey : Lawrence Erlbaum Associates .
  • Maggiolo , F. , Ripamonti , D. , Arici , C. , Gregis , G. , Quinzan , G. , Camacho , G.A. and Suter , F. 2002 . Simpler regimens may enhance adherence to antiretrovirals in HIV infected patients . HIV Clinical Trials , 5 : 371 – 378 .
  • Max , B and Sherer , R. 2000 . Management of the adverse effects of antiretroviral therapy and medication adherence . Clinical Infectious Diseases , 30 : S96 – S116 .
  • Murphy , D.A. , Belzer , M. , Durako , S.J. , Sarr , M. , Wilson , C.M. , Muenz , L.R. , & Adolescent Medicine HIV/AIDS Research Network 2005 . Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus . Archives of Pediatrics and Adolescent medicine 159 , 764 – 760 .
  • Murphy , D.A. , Wilson , C.M. , Durako , S.J. , Muenz , L.R. , Belzer , M. , & Adolescent Medicine HIV/AIDS Research Network 2001 . Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA . AIDS Care 13 , 27 – 40 .
  • Palmisano , L. , Giuliano , M. , Nicastri , E. , Pirillo , M.F. , Andreotti , M. , Galluzzo , C.M. and Vella , S. 2005 . Residual viraemia in subjects with chronic HIV infection and viral load <50 copies/mL: The impact of highly active antiretroviral therapy . AIDS , 19 : 1843 – 1847 .
  • Rudy , B.J. , Lindsey , J.C. , Flynn , P.M. , Bosch , R.J. , Wilson , C.M. , Hughes , M.E. , Pediatric AIDS Clinical Trials Group 381 Study Team 2006 . Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviours and initiating HAART: Week 60 results from the PACTG 381 cohort . AIDS Research and Human Retroviruses 22 , 213 – 221 .
  • Rudy , B.J. , Murphy , D.A. , Harris , D.R. , Muenz , L. , Ellen , J. , & Adolescent Trials Network for HIV/AIDS Interventions 2010 . Prevalence and interactions of patient-related risks for non adherence to antiretroviral therapy among perinatally infected youth in the United States . AIDS Patient Care STDs 24 , 97 – 104 .
  • Ryan , M. , Griffin , S. , Chitah , B. , Walker , A.S. , Mulenga , V. , Kalolo , D. and Gibb , D.M. 2008 . The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia . AIDS , 22 : 749 – 757 .
  • Shah , B. , Walshe , L. , Saple , D.G. , Mehta , S.H. , Ramnani , J.P. , Kharkar , R.D. and Gupta , A. 2007 . Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India . Clinical Infectious Diseases , 44 : 1235 – 1244 .
  • Stone , V.E. , Jordan , J. , Tolson , J. , Miller , R. , & Pilon , T. 2004 . Perspectives on adherence and simplicity of HIV-infected patients on antiretroviral therapy. Self-report of the relative importance of multiple attributes of Highly Active Antiretroviral Therapy (HAART) regimens in predicting adherence . Journal of Acquired Immune Deficiency Syndromes 36 , 808 – 816
  • Trotta , M.P. , Ammassari , A. , Cozzi-Lepri , A. , Zaccarelli , M. , Castelli , F. , Narciso , P. . Adherence Spallanzani (AdeSpall) Study Group 2003 . Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than those receiving protease inhibitor-containing regimens . AIDS 17 , 1099 – 1102 .
  • Van Dyke , R.B. , Lee , S. , Johnson , G.M. , Wiznia , A. , Mohan , K. , Stanley , K. Pediatric AIDS Clinical Trials Group Adherence Subcommittee Pediatric AIDS Clinical Trials Group 377 Study Team 2002 . Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection . Pediatrics 109 , e61 .
  • Watson , D.C. and Farley , J.J. 1999 . Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1 . The Pediatric Infectious Disease Journal , 18 : 682 – 689 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.